Patents by Inventor Josée Harel

Josée Harel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies for preventing and treating attaching and effacing (AEEC) associated diseases
    Patent number: 8623372
    Abstract: The present invention relates to antibodies immunologically specific for an attaching and effacing Escherichia coli (AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: January 7, 2014
    Assignee: Valorisation-Recherche, Societe En commandite
    Inventors: John M. Fairbrother, Josée Harel, Isabelle Batisson, Francis Girard, Marie-Pierre Guimond
  • polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
    Patent number: 7927608
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: September 1, 2006
    Date of Patent: April 19, 2011
    Assignee: Valorisation—Recherche Limited Partnership
    Inventors: Josée Harel, Marcelo Gottschalk, Yuanyi Li
  • ANTIBODIES FOR PREVENTING AND TREATING ATTACHING AND EFFACING ESCHERICHIA COLI (AEEC) ASSOCIATED DISEASES
    Publication number: 20100183627
    Abstract: The present invention relates to antibodies immunologically specific for an attaching and effacing Escherichia coli (AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa.
    Type: Application
    Filed: March 26, 2010
    Publication date: July 22, 2010
    Inventors: John M. Fairbrother, Josée Harel, Isabelle Batisson, Francis Girard, Marie-Pierre Guimond
  • Antibodies for preventing and treating attaching and effacing (AEEC) associated diseases
    Patent number: 7727531
    Abstract: The present invention relates to antibodies immunologically specific for an attaching and effacing Escherichia coli (AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: June 1, 2010
    Assignee: Valorisation-Recherche, Societe En commandite
    Inventors: John M. Fairbrother, Josée Harel, Isabelle Batisson, Francis Girard, Marie-Pierre Guimond
  • STREPTOCOCCUS SUIS POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND THEIR USE IN VACCINAL AND DIAGNOSTIC APPLICATIONS
    Publication number: 20090220513
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Application
    Filed: September 1, 2006
    Publication date: September 3, 2009
    Applicant: Universite de Montreal
    Inventors: Josee Harel, Marcelo Gottschalk, Yuanyi Li
  • ANTIBODIES FOR PREVENTING AND TREATING ATTACHING AND EFFACING ESCHERICHIA COLI (AEEC) ASSOCIATED DISEASES
    Publication number: 20090092621
    Abstract: The present invention relates to antibodies immunologically specific for an attaching and effacing Escherichia coli (AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa.
    Type: Application
    Filed: October 24, 2008
    Publication date: April 9, 2009
    Inventors: John M. Fairbrother, Josee Harel, Isabelle Batisson, Francis Girard, Marie-Pierre Guimond
  • Antibodies for preventing and treating attaching and effacing (AEEC) associated diseases
    Patent number: 7445782
    Abstract: The present invention relates to antibodies immunologically specific for an attaching and effacing Escherichia coli (AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: November 4, 2008
    Assignee: Valorisation-Recherche, Societe en Commandite
    Inventors: John M. Fairbrother, Josée Harel, Isabelle Batisson, Francis Girard, Marie-Pierre Guimond
  • Array and uses thereof
    Publication number: 20040219530
    Abstract: An array of nucleic acid probes is described for identifying and/or characterizing a pathotype of a microorganism. Methods are also described for detecting the presence of a microorganism in a sample, as well as determining its pathotype, using the array. Methods of assessing related infection and disease in a subject using the array are also described.
    Type: Application
    Filed: April 30, 2003
    Publication date: November 4, 2004
    Inventors: Roland Brousseau, Josee Harel, Sadjia Bekal
  • Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases
    Publication number: 20040086513
    Abstract: The present invention relates to antibodies immunologically specific for an attaching and effacing Escherichia coli (AEEC) virulence-associated protein, products, compositions and methods and to their use thereof in the prevention of an AEEC infection in a mammal. The antibody of the invention is immunologically specific for an AEEC virulence-associated protein and is capable of preventing an in vivo AEEC intestinal infection when administered to a mammal. The antibody of the invention is preferably useful for preventing the development of A/E intestinal lesions associated with the AEEC. This is achieved by preferably using IgY antibodies immunologically specific for one or more AEEC virulence-associated proteins, such as Eae, Tir, EspA and Paa.
    Type: Application
    Filed: November 12, 2003
    Publication date: May 6, 2004
    Inventors: John M. Fairbrother, Josee Harel, Isabelle Batisson, Francis Girard, Marie-Pierre Guimond
  • polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
    Patent number: RE45467
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: April 14, 2015
    Assignee: Valorisation-Recherche, Limited Partnership
    Inventors: Josee Harel, Marcelo Gottschalk, Yuanyi Li
  • polypeptides and polybnucleotides encoding same and their use in vaccinal and diagnostic applications
    Patent number: RE46285
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: January 24, 2017
    Assignee: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
    Inventors: Josée Harel, Marcelo Gottschalk, Yuanyi Li
  • polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
    Patent number: RE47164
    Abstract: The present invention relates to the field of Streptococcus. More specifically, the present invention relates to the identification of polypeptides and polynucleotide sequences encoding the same which are involved in the pathogenic mechanism of S. suis. The present invention also relates to the use of such polypeptides in compositions and methods for the prevention, the treatment and diagnosis of S. suis-associated diseases and infections caused by S. suis.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: December 18, 2018
    Assignee: Valorisation-Recherche Limited Partnership
    Inventors: Josee Harel, Marcelo Gottschalk, Yuanyi Li